Medicine
Signifor LAR kit
Signifor LAR kit is a prescription medicine containing Pasireotide, marketed by Recordati Rare Diseases, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store at 2°C to 8°C (36°F-46°F). Do not freeze. SIGNIFOR LAR should be stored…
Key facts
- Active ingredient (INN)
- Pasireotide
- Brand
- Signifor LAR
- Dosage form
- Kit
- Packs
- 1 kit and 2 more
- Marketing authorisation holder
- Recordati Rare Diseases
- Manufacturer
- Recordati Rare Diseases
- Origin register
- US FDA, United States
- Storage
- Store at 2°C to 8°C (36°F-46°F). Do not freeze. SIGNIFOR LAR should be stored at refrigerated temperatures between 2°C to 8°C (36°F-46°F) until the time of use. Do not freeze. SIGNIFOR LAR drug product kit should remain at room temperature for a minimum of 30 minutes before reconstitution, but should not exceed 24 hours at room temperature.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01CB05 Pasireotide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 December 2014
- Identifiers
- RxCUI 1597596, 1597599, 1597601 +7DailyMed set ID a0aad470-3f38-af97-e053-2995a90a383aNDC 55292-141, 55292-143, 55292-139 +2Application NDA203255
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 kit * 6 mL in 1 vial, single-use * 2 mL in 1 syringe | 55292-139-01 | Recordati Rare Diseases | 29 June 2018 |
| 1 kit in 1 kit * 6 mL in 1 vial, single-use * 2 mL in 1 syringe | 55292-140-01 | Recordati Rare Diseases | 15 December 2014 |
| 1 kit in 1 kit * 6 mL in 1 vial, single-use * 2 mL in 1 syringe | 55292-141-01 | Recordati Rare Diseases | 29 June 2018 |
| 1 kit in 1 kit * 6 mL in 1 vial, single-use * 2 mL in 1 syringe | 55292-142-01 | Recordati Rare Diseases | 15 December 2014 |
| 1 kit in 1 kit * 6 mL in 1 vial, single-use * 2 mL in 1 syringe | 55292-143-01 | Recordati Rare Diseases | 15 December 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Pasireotide
Clinical summary
Pasireotide is a somatostatin analog indicated for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option, among other approved uses. MedsAcross supplies Pasireotide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PasireotideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Signifor LAR prescribing information (Recordati Rare Diseases) · U.S. National Library of Medicine, DailyMed
- Signifor: European public assessment report (EPAR) · European Medicines Agency
Need Signifor LAR kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.